Global Antithyroid Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Antithyroid Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Antithyroid drug is a drug for the treatment of hyperthyroidism. It mainly reduces the secretion of thyroid hormone by inhibiting thyroid synthesis.
Antithyroid Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antithyroid Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Medical Treatment of Hyperthyroidism and Preparation for Thyroid Surgery are the major drivers for the industry.
The next decade will be full of promise in thyroid cancer diagnosis and treatment.With the increasing incidence of thyroid cancer, the scientific cognition of professionals and the public will also be further improved. There will be more investment in basic research, more targeted drugs will be developed and better drug efficacy will be achieved.Therefore, the anti-thyroid drug market still has a lot of room for growth in the future.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antithyroid Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Shanghai Huanghai Pharmaceutical Co., Ltd
Merck KGaA
Lomapharm Rudolf Lohmann GmbH KG
Herbrand Pharmaceutical Chemistry Co., Ltd
Beijing Tongjida Pharmaceutical Co., Ltd
Shanghai Zhaohui Pharmaceutical Co., Ltd
Guangzhou Kanghe Pharmaceutical Co., Ltd
Hunan Hansen Pharmaceutical Co., Ltd
World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd
Haimani Pharmaceutical Co., Ltd
Shanghai McLin Biochemical Technology Co., Ltd
Shanghai Yuanye Bio-Technology Co., Ltd
Amgen Inc
AbbVie Deutschland GmbH & Co.KG
Centrix Pharmaceutical Inc.
Pfizer Inc.
Actavis Totowa LLC
Caraco Pharmaceutical Laboratories
Boca Pharmacal Inc.
Heritage Pharmaceuticals Inc.
Par Pharmaceutical Inc
Sandoz Pharmaceuticals Inc.
Segment by Type
Thiourea
Iodine and Iodide
Radioiodine
β Receptor Blockers
Medical Treatment of Hyperthyroidism
Preparation for Thyroid Surgery
Treatment of Thyroid Crisis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Antithyroid Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Antithyroid Drug introduction, etc. Antithyroid Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Antithyroid Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Antithyroid Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antithyroid Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Medical Treatment of Hyperthyroidism and Preparation for Thyroid Surgery are the major drivers for the industry.
The next decade will be full of promise in thyroid cancer diagnosis and treatment.With the increasing incidence of thyroid cancer, the scientific cognition of professionals and the public will also be further improved. There will be more investment in basic research, more targeted drugs will be developed and better drug efficacy will be achieved.Therefore, the anti-thyroid drug market still has a lot of room for growth in the future.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antithyroid Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Shanghai Huanghai Pharmaceutical Co., Ltd
Merck KGaA
Lomapharm Rudolf Lohmann GmbH KG
Herbrand Pharmaceutical Chemistry Co., Ltd
Beijing Tongjida Pharmaceutical Co., Ltd
Shanghai Zhaohui Pharmaceutical Co., Ltd
Guangzhou Kanghe Pharmaceutical Co., Ltd
Hunan Hansen Pharmaceutical Co., Ltd
World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd
Haimani Pharmaceutical Co., Ltd
Shanghai McLin Biochemical Technology Co., Ltd
Shanghai Yuanye Bio-Technology Co., Ltd
Amgen Inc
AbbVie Deutschland GmbH & Co.KG
Centrix Pharmaceutical Inc.
Pfizer Inc.
Actavis Totowa LLC
Caraco Pharmaceutical Laboratories
Boca Pharmacal Inc.
Heritage Pharmaceuticals Inc.
Par Pharmaceutical Inc
Sandoz Pharmaceuticals Inc.
Segment by Type
Thiourea
Iodine and Iodide
Radioiodine
β Receptor Blockers
Segment by Application
Medical Treatment of Hyperthyroidism
Preparation for Thyroid Surgery
Treatment of Thyroid Crisis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Antithyroid Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Antithyroid Drug introduction, etc. Antithyroid Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Antithyroid Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices